[
1. Tripolino C, Ciaffi J, Ruscitti P et al. Hyperuricemia in Psoriatic Arthritis: Epidemiology, Pathophysiology and Clinical Implications. Front Med. 2021; 8:737573.
]Search in Google Scholar
[
2. Lyngdoh T, Marques-Vidal P, Paccaud F et al. Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study. PLoS One. 2011;6:e19901.
]Search in Google Scholar
[
3. Ibrahim SE, Helmi A, Yousef TM et al. Association of asymptomatic hyperuricemia and endothelial dysfunction in psoriatic arthritis. Egyptian Rheumatologist. 2012; 34:83-9. doi: 10.1016/j.ejr.2012.03.002.
]Open DOISearch in Google Scholar
[
4. Gisondi P, Targher G, Cagalli A, Girolomoni G. Hyperuricemia in patients with chronic plaque psoriasis. J Am Acad Dermatol. 2014;70:127-30.
]Search in Google Scholar
[
5. Lai TL, Yim CW, Wong PY et al. Hyperuricemia in Asian psoriatic arthritis patients Int J Rheum Dis. 2018; 21(4):843-849.
]Search in Google Scholar
[
6. Chu BBR, Chuha JPV, Marcon JMT. Does disease activity Influence the levels of Uric acid in Psoriatic Arthritis? The Open Rheumatology Journal. 2021; 15:57-64.
]Search in Google Scholar
[
7. Goldman M. Uric acid in the etiology of psoriasis. Am J Dermatopathol. 1981; 3:397-404. doi: 10.1097/00000372-198100340-00014.
]Open DOISearch in Google Scholar
[
8. Raucci F, Iqbal AJ, Saviano A et al. IL-17A neutralizing antibody regulates monosodium urate crystalinduced gouty inflammation. Pharmacol Res. 2019; 147:104351. doi: 10.1016/j.phrs.2019.104351.
]Open DOISearch in Google Scholar
[
9. Klück V, Liu R, Joosten LAB. The role of interleukin-1 family members in hyperuricemia and gout. Joint Bone Spine. 2021; 88:105092. doi: 10.1016/j.jbspin.2020.105092.
]Open DOISearch in Google Scholar
[
10. Chizyński K, Rózycka M. Hyperuricemia. Pol. Merkur. Lekarski (in Polish). 2005; 19 (113): 693-6. PMID 16498814.
]Search in Google Scholar
[
11. Backhaus M, Burmester GR, Gerber T, et al. Guidelines for musculoskeletal ultrasound in rheumatology. Ann Rheum Dis. 2001; 60:641-9.
]Search in Google Scholar
[
12. Beringer A, Miossec P. Systemic effects of IL-17 in inflammatory arthritis. Nat Rev Rheumatol. 2019; 15:491-501. doi: 10.1038/s41584-019-0243-5.
]Open DOISearch in Google Scholar
[
13. Szendroedi J, Chmelik M, Schmid AI et al. Abnormal hepatic energy homeostasis in type 2 diabetes. Hepatology. 2009; 50:1079-86. doi: 10.1002/hep.23093 54.
]Open DOISearch in Google Scholar
[
14. Cortez-Pinto H, Chatham J, Chacko VP et al. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA. 1999; 282:1659-64. doi: 10.1001/jama.282.17.1659.
]Open DOISearch in Google Scholar
[
15. Petrie JL, Patman GL, Sinha I et al. The rate of production of uric acid by hepatocytes is a sensitive index of compromised cell ATP homeostasis. Am J Physiol Endocrinol Metab. 2013; 305:E1255-65. doi: 10.1152/ajpendo.00214.2013.
]Open DOISearch in Google Scholar
[
16. Hosomi A, Nakanishi T, Fujita T, Tamai I. Extra-renal elimination of uric acid via intestinal efflux transporter BCRP/ABCG2. PLoS ONE. 2012; 7:e30456. doi: 10.1371/journal. pone.0030456.
]Open DOISearch in Google Scholar
[
17. Fieldhouse KA, Ukaibe S, Crowley EL et al. Inflammatory bowel disease in patients with psoriasis treated with interleukin-17 inhibitors. Drugs Context. 2020 Apr 21; 9:2020-2-1.
]Search in Google Scholar
[
18. Takada T, Ichida K, Matsuo H et al. ABCG2 dysfunction increases serum uric acid by decreased intestinal urate excretion. Nucleosides Nucleotides Nucleic Acids. 2014; 33:275-81. doi: 10.1080/15257770.2013.85490259.
]Open DOISearch in Google Scholar
[
19. Englund G, Jacobson A, Rorsman F et al. Efflux transporters in ulcerative colitis: decreased expression of BCRP. (ABCG2) and Pgp. (ABCB1). Inflamm Bowel Dis. 2007; 13:291-7. doi: 10.1002/ibd.20030.
]Open DOISearch in Google Scholar
[
20. Perez-Chada LM, Merola JF. Comorbidities associated with psoriatic arthritis: Review and update. Clin Immunol. 2020; 214:108397. doi: 10.1016/j.clim.2020.108397.
]Open DOISearch in Google Scholar
[
21. Gong M, Wen S, Nguyen T et al. Converging relationships of obesity and hyperuricemia with special reference to metabolic disorders and plausible therapeutic implications. Diabetes Metab Syndr Obes. 2020; 13:943-62. doi: 10.2147/DMSO. S232377.
]Open DOISearch in Google Scholar
[
22. Xu L, Shi Y, Zhuang S, Liu N. Recent advances on uric acid transporters. Oncotarget. 2017; 8:100852-62. doi: 10.18632/oncotarget.20135.
]Open DOISearch in Google Scholar
[
23. Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodriguez TR et al. Asymptomatic hyperuricemia and serum uric acid concentration correlate with subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease. Semin Arthritis Rheum. 2009; 39:157-62. doi: 10.1016/j.semarthrit.2008.06.001.
]Open DOISearch in Google Scholar
